Both in Biotechnology
Kyverna Therapeutics vs Scribe Therapeutics
Over the past year KYTX returned −28.9% and SCTX returned −45.5%; their daily moves had a correlation of 0.31.
KYTX −28.9% SCTX −45.5%Growth of $1, one year, split-adjusted
| Metric | KYTX | SCTX |
|---|---|---|
| Price | $5.16 | $16.20 |
| Market cap | $319.1M | $306.7M |
| Today | −1.15% | +4.25% |
| 1 month | −18.4% | −0.1% |
| 6 months | −44.0% | — |
| Year to date | −45.1% | — |
| 1 year | −26.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $174.4M | — |
| Dividend yield | — | — |
| Volatility (60d) | 59.9% | — |
| Short % of float | 26.6% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).